Issue 3/2017

Detection and characterization of ciRS-7: a potential promoter of the development of cancer (321 — 328)

X. B. ZHENG, M. ZHANG, M. Q. XU

DOI: 10.4149/neo_2017_301

Patterns of failure after brain metastases radiotherapy: reflections on the importance for treatment and clinical trials reporting (329 — 337)

R. LAKOMY, L. HYNKOVA, P. POSPISIL, P. BURKON, M. SLAVIK, P. SLAMPA, R. JANCALEK, T. KAZDA

DOI: 10.4149/neo_2017_302

Novel strategies for comprehensive mutation screening of the APC gene (338 — 343)

L. WACHSMANNOVA, M. MEGO, V. STEVURKOVA, V. ZAJAC, S. CIERNIKOVA

DOI: 10.4149/neo_2017_303

Secalonic acid- F inhibited cell growth more effectively than 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo (344 — 350)

X. GAO, H. L. SUN, D. S. LIU, J. R. ZHANG, J. ZHANG, M. M. YAN, X. H. PAN

DOI: 10.4149/neo_2017_304

Microarray expression analysis of MYCN-amplified neuroblastoma cells after inhibition of CDK2 (351 — 357)

H. SONG, F. WU, S. LI, Z. WANG, X. LIU, Y. CUI, C. LIN

DOI: 10.4149/neo_2017_305

MicroRNA-1285 inhibits malignant biological behaviors of human pancreatic cancer cells by negative regulation of YAP1 (358 — 366)

H. HUANG, G. XIONG, P. SHEN, Z. CAO, L. ZHENG, T. ZHANG, Y. ZHAO

DOI: 10.4149/neo_2017_306

ARID1A gene knockdown promotes neuroblastoma migration and invasion (367 — 376)

C. LI, Z. L. XU, Z. ZHAO, Q. AN, L. WANG, Y. YU, D. X. PIAO

DOI: 10.4149/neo_2017_307

PHA665752 inhibits the HGF-stimulated migration and invasion of cells by blocking PI3K/AKT pathway in uveal melanoma (377 — 388)

Z. WANG, C. HE, L. LIU, N. MA, X. CHEN, D. ZHENG, GH. QIU

DOI: 10.4149/neo_2017_308

TNFAIP3 inhibits migration and invasion in nasopharyngeal carcinoma by suppressing epithelial mesenchymal transition (389 — 394)

T. HUANG, L. YIN, J. WU, J. J. GU, K. DING, N. ZHANG, M. Y. DU, L. X. QIAN, Z. W. LU, X. HE

DOI: 10.4149/neo_2017_309

Activation of the cell membrane angiotensin AT2 receptors in human leiomyosarcoma cells induces differentiation and apoptosis by a PPARγ – dependent mechanism (395 — 405)

U. LÜTZEN, Y. ZHAO, K. LUCHT, M. ZUHAYRA, J. HEDDERICH, I. CASCORBI, J. CULMAN

DOI: 10.4149/neo_2017_310

The potential roles of vesicle-enclosed miRNAs in communication between macrophages and cancer cells in tumor microenvironment (406 — 411)

M. KORABECNA, L. KOUTOVA, P. TESAROVA

DOI: 10.4149/neo_2017_311

Expression of DNA methylation-related proteins in metastatic breast cancer (412 — 420)

Y. J. CHA, W. H. JUNG, J. S. KOO

DOI: 10.4149/neo_2017_312

Enterohormonal disturbances in colorectal cancer patients (421 — 429)

A. L. ZYGULSKA, A. FURGALA, K. KRZEMIENIECKI, J. KASZUBA-ZWOINSKA, P. THOR

DOI: 10.4149/neo_2017_313

Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging (430 — 436)

H. D. XU, Y. Q. ZHANG

DOI: 10.4149/neo_2017_314

Effect of small and radical surgical injury on the level of different populations of circulating tumor cells in the blood of breast cancer patients (437 — 443)

E. V. KAIGORODOVA, N. A. TARABANOVSKAYA, M. N. STAHEEVA, O. E. SAVELIEVA, L. A. TASHIREVA, E. V. DENISOV, V. M. PERELMUTER

DOI: 10.4149/neo_2017_315

Predictive value of serum gamma-glutamyltransferase levels in patients with hepatocellular carcinoma (444 — 452)

L. SUN, R. WANG, F. Y. GAO, Y. X. LI, M. F. GENG, J. L. CHEN, X. Q. YE, X. S. LI, X. YANG, G. WAN, Z. Y. YANG, X. B. WANG

DOI: 10.4149/neo_2017_316

Predicative values of serum microRNA-22 and microRNA-126 levels for non-small cell lung cancer development and metastasis: a case-control study (453 — 459)

A. Q. SHANG, Y. N. XIE, J. WANG, L. SUN, J. WEI, W. Y. LU, J. Y. LAN, W. W. WANG, L. WANG, L. L. WANG

DOI: 10.4149/neo_2017_317

Morbidity, mortality and long term survival in patients with vascular resection in pancreatic cancer – single center experience (460 — 463)

D. PINDAK, M. TOMAS, J. DOLNIK, R. DUCHON, J. PAVLENDOVA

DOI: 10.4149/neo_2017_318

Gastrointestinal stromal tumor after tyrosine kinase inhibition therapy: a review of biopsies of 34 patients with clinically suspected relapse and/or progression of the tumor (464 — 473)

L. PLANK, V. BUZALKOVA, P. SZEPE, Z. LASABOVA, K. JASEK, A. STANCLOVA, G. MINARIK, J. SUFLIARSKY

DOI: 10.4149/neo_2017_319

Infectious complications in chronic lymphocytic leukemia- a retrospective analysis: single institution experience (474 — 481)

L. DEMITROVICOVA, E. MIKUSKOVA, I. ORAVCOVA, S. CINGELOVA, L. DRGONA, B. MLADOSIEVICOVA

DOI: 10.4149/neo_2017_320